Update on minimally invasive surgery and benign prostatic hyperplasia.

Area of Science:

• Urology
• Minimally Invasive Surgery

Background:

• Transurethral resection of the prostate (TURP) is the established gold standard for benign prostatic obstruction.
• Historically, TURP has been linked to significant patient morbidity.
• Advancements in TURP have set a high benchmark for new surgical technologies.

Purpose of the Study:

• To review novel minimally invasive surgical (MIS) options for benign prostatic obstruction.
• To evaluate emerging technologies against the current TURP standard.
• To focus on literature published within the last five years.

Main Methods:

• Literature review of novel MIS treatments for benign prostatic obstruction.
• Analysis of studies published in the past 5 years.
• Comparison of efficacy and safety profiles of emerging technologies.

Main Results:

• Several novel MIS options have emerged, including prostatic urethral lift (PUL), convective water vapor energy (WAVE), Aquablation, histotripsy, and temporary implantable nitinol devices (TIND).
• Intraprostatic injections show limited efficacy but may suit specific patient groups.
• The review assesses these options against the continually improving TURP standard.

Conclusions:

• Minimally invasive surgical options are evolving as alternatives to TURP for benign prostatic obstruction.
• These new technologies aim to reduce perioperative morbidity associated with traditional TURP.
• Further evaluation is needed to establish the long-term efficacy and safety of these novel treatments.